How This Works
Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that binds to GHRH receptors on pituitary somatotropes, stimulating endogenous pulsatile GH secretion[1]. Unlike exogenous GH preparation, sermorelin preserves physiologic feedback loops—GH release is subject to normal negative feedback via somatostatin and IGF‑1, reducing the risk of excessive GH or IGF‑1 levels[6]. This pulsatile GH output then promotes hepatic and peripheral IGF‑1 production, supporting anabolic processes such as protein synthesis, lipolysis, and tissue repair. Pediatric studies in idiopathic GH deficiency demonstrated significant improvements in height velocity over 6–12 months of nightly research at 30 µg/kg[1]. In adults, off‑label use aims to restore age‑related declines in GH output, though robust adult trial data are limited and measurement is extrapolated from pediatric and physiologic studies[2]. Sermorelin requires a functional pituitary to be effective and will not work in cases of pituitary damage or primary GH gene defects.
References
PubMed
— Prakash & Goa (1999): Sermorelin: a review of its use in the diagnosis and research model of children with idiopathic growth hormone deficiency (pediatric GHD; 30 µg/kg SC nightly; 6–12 month trials)
RxList
— Sermorelin Acetate Measurement Monograph: measurement (0.2–0.3 mg SC qHS adult off‑label); reconstitution/storage/preparation guidelines
PubMed
— Clinical studies: bedtime SC measurement leverages natural nocturnal GH pulse; once‑daily nightly measurement yielded significant growth improvements in pediatric GHD over 6–12 months
Mayo Clinic
— Sermorelin (measurement route) – Proper Use and Storage: refrigerate reconstituted solution at 2–8 °C (36–46 °F); do not freeze; use within recommended period
RxList
— Sermorelin Acetate Prescribing Information: adverse effects (measurement‑site reactions ~17%; rare headache/flushing <1%); subclinical hypothyroidism ~6.5%; thyroid monitoring recommended
PubMed
— Sermorelin mechanism: stimulates endogenous pulsatile GH via GHRH receptors; preserves physiologic feedback loops (somatostatin/IGF‑1 negative feedback); reduces overdose risk vs. exogenous GH
Johns Hopkins Arthritis Center
— How to Give a Measurement: site selection (abdomen/thigh/arm); rotation guidelines; 45–90° angle; pinch technique; no aspiration; disposal in sharps container
CDC
— Vaccine preparation: route technique (45–90° angle; site prep; no aspiration for SC measurements)
PubMed
— Sermorelin measurement considerations: higher doses (up to 500 µg daily) used in research for greater IGF‑1 response in adults; aging/obesity associated with blunted GH release; cautious titration recommended
RxList
— Sermorelin research model duration: pediatric studies 6–12 months daily research with sustained effect; some continued up to 36 months; adult off‑label cycles typically 3–6 months to evaluate efficacy
NCBI Bookshelf
— Best practices for parenteral measurements: aseptic technique, preparation, preparation guidelines
RxList
— Sermorelin safety profile: no serious acromegaly or hypoglycemia at recommended dosages; built‑in negative feedback prevents excessive GH/IGF‑1; FDA‑approved (as Geref) for decades with good safety record
